Conference
Sponsored by
TBA

TBA
Title sponsor
content
Life Sciences Conference
Now in its second year, Scotland’s Life Sciences Conference returns with an expanded programme designed to spark collaboration, share insight, and tackle the most pressing topics shaping the sector’s future.
This year’s themes, Commercialisation: From Discovery to Delivery and Integrating AI into Life Sciences, will bring together leaders, innovators, and investors to explore how science moves from breakthrough to impact, and how technology is redefining what’s possible in health and life sciences.
The conference will begin midday with a networking lunch, offering an opportunity for attendees to connect. Following this, we will dive into a series of insightful presentations and panel discussions, where industry leaders and experts will explore these critical topics in depth.
Starts at
12:00
Thursday 12 March 2026
Cambridge Suite @Doubletree Hilton
Glasgow Central
Sponsored by
TBA

TBA
Title sponsor
content
Why should I attend?
Scotland’s Life Sciences Conference is the premier gathering for anyone looking to stay ahead in the rapidly evolving life sciences sector. Whether you are a researcher, entrepreneur, investor, or policy-maker, this conference offers a unique opportunity to:
Connect with leading figures across academia, industry, and investment.
Gain insights into the latest breakthroughs, regulatory trends, and market opportunities.
Explore how emerging technologies like AI are transforming discovery, development, and delivery in life sciences.
Discover pathways to commercialisation and investment that can accelerate your projects from lab to market.
What will I gain from attending?
Attending the conference will leave you equipped with knowledge, connections, and inspiration to drive impact in your work. You will:
Learn actionable strategies for turning scientific innovation into viable, market-ready solutions.
Engage directly with investors and partners, opening doors for collaboration and funding.
Understand the regulatory and technological landscape shaping the future of health and life sciences.
Take part in discussions that challenge assumptions, spark new ideas, and highlight emerging opportunities.
Return to your organisation with insights and connections that can influence strategy, innovation, and growth.
Who should attend?
Innovators
Industry Leaders
Academia
University Spin-offs
Investors
Entrepreneurs
Policy Makers
Start Ups
Programme
1200
Networking Lunch
1200
Networking Lunch
1200
Networking Lunch

Mark Cook
Co-Chair Industry Leadership Group, Life Sciences Scotland
Mark has spent 30 years in roles within the health sector including biologicals/pharmaceuticals, medical technology and consultancy.
In February 2022 Mark became Co Chair of the Life Sciences Industrial Leadership Group in Scotland, he also continues to support decision making for non-medicine technologies through membership of the Scottish Health Technology Group plus, in conjunction with the Chief Scientist Office, raises the profile for the Life Sciences Sector in Scotland. Mark chairs a company working towards accelerating the cure for Alzheimer’s as well as looking after one of Scotland’s public pension schemes as its Independent Chair.
Life Science is a sector that is actively growing, will provide careers for our population at higher than average salaries, will increase the tax base of Scotland and do societal good by bringing forward innovative and transformational changes that will improve the health of our population.
Current focus for the Life Sciences ILG is the refresh of the sector strategy ( which runs until 2025 ) and Mark is leading on this having exceed our goal of £8 Billion generated by the Scottish Life Sciences sector by 2025 by over £2 billion 4 years early.
1300
Introduction
1315
Keynote Speaker
Panel Session:
Commercialisation: From Discovery to Delivery
Scotland’s life sciences sector is home to world-leading research and innovation but translating that into commercial success remains a defining challenge. This session will explore how we can better support the full innovation journey, from lab bench to global markets.
We’ll examine the practical realities of building investable ventures, accessing capital, managing risk, and navigating regulation, while celebrating the companies and leaders turning Scottish science into real-world impact. How can we scale more ideas, faster, and make Scotland a global hub for life sciences commercialisation?
1400
Panel Session:
Commercialisation: From Discovery to Delivery
1500
Networking Break
Panel Session:
AI promises to revolutionise life sciences but how are companies making it work in practice? This session will highlight real-world applications where AI is solving problems, improving efficiency, and creating business impact.
We’ll hear from leaders who have successfully embedded AI into their organisations, exploring the opportunities, challenges, and compliance hurdles along the way. From SMEs to global players, this is a look at how AI is being integrated into life sciences today and what it means for the future of the sector.
1520
Panel Session:
Integrating AI into Life Sciences Businesses